Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User, By Region, And Segment Forecasts, 2025-2034
Segmentation of Transplant Diagnostics Market-
Transplant Diagnostics Market By Technology-
- Molecular assay technologies
- PCR based molecular assays
- Real-time PCR
- Sequence-specific primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based molecular assays
- Sequencing based molecular assays
- Sanger sequencing
- Next generation sequencing
- Others
- Non molecular assays technologies
Transplant Diagnostics Market By Product & Service-
- Reagents & Consumables
- Instruments
- Software & Services
Transplant Diagnostics Market By Application-
- Diagnostic application
- Pre-transplantation
- Infectious Disease testing
- Histocompatibility testing
- Blood profiling
- Post-transplantation diagnostics
- Pre-transplantation
- Research applications
Transplant Diagnostics Market By Transplant Type-
- Solid organ transplantation
- Kidney
- Liver
- Heart
- Lung
- Pancreases
- Others
- Stem Cell Transplantation
- Soft Tissue Transplantation
- Bone Marrow Transplantation
Transplant Diagnostics Market By End-User-
- Hospitals & Transplant Centers
- Research & Academic Institutes
- Independent Research Laboratories
Transplant Diagnostics Market By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Transplant Diagnostics Market Snapshot
Chapter 4. Global Transplant Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
5.2.1. Molecular assay technologies
5.2.1.1. PCR-based molecular assays
5.2.1.2. Real-time PCR
5.2.1.3. Sequence-specific primer-PCR
5.2.1.4. Sequence-specific Oligonucleotide-PCR
5.2.1.5. Other PCR-based molecular assays
5.2.2. Sequencing based molecular assays
5.2.2.1. Sanger sequencing
5.2.2.2. Next generation sequencing
5.2.2.3. Other sequencing based molecular assays
5.2.3. Non molecular assays technologies
Chapter 6. Market Segmentation 2: by Product & Service Estimates & Trend Analysis
6.1. by Product & Service & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product & Service:
6.2.1. Reagents & Consumables
6.2.2. Instruments
6.2.3. Software & Services
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Diagnostic Application
7.2.1.1. Pre-Transplantation Diagnostics
7.2.1.1.1. Infectious Disease Testing
7.2.1.1.2. Histocompatibility Testing
7.2.1.1.3. Blood Profiling
7.2.1.2. Post -Transplantation Diagnostics
7.2.2. Research Applications
Chapter 8. Market Segmentation 4: by Transplant Type Estimates & Trend Analysis
8.1. by Transplant Type & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Transplant Type:
8.2.1. Solid Organ Transplantation
8.2.1.1. Kidney Transplantation
8.2.1.2. Liver Transplantation
8.2.1.3. Heart Transplantation
8.2.1.4. Lung Transplantation
8.2.1.5. Pancreases Transplantation
8.2.1.6. Other Organs Transplantation
8.2.2. Stem Cell Transplantation
8.2.3. Soft Tissue Transplantation
8.2.4. Bone Marrow Transplantation
Chapter 9. Market Segmentation 5: by End-user Estimates & Trend Analysis
9.1. by End-user & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
9.2.1. Hospitals and Transplant centers
9.2.2. Research &Academic Institutes
9.2.3. Independent reference laboratories
Chapter 10. Transplant Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.1.2. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
10.1.3. North America Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.1.4. North America Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.1.5. North America Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.1.6. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.2.2. Europe Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.2.3. Europe Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.2.4. Europe Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.2.5. Europe Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.2.6. Europe Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.3.2. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.3.3. Asia-Pacific Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.3.4. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.3.5. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.3.6. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.4.2. Latin America Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.4.3. Latin America Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.4.4. Latin America Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.4.5. Latin America Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.4.6. Latin America Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.5.2. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.5.3. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.5.4. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.5.5. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.5.6. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott Laboratories, Inc.
11.2.2. Adaptive Biotechnologies
11.2.3. Affymetrix, Inc.
11.2.4. altona Diagnostics GmbH
11.2.5. Arquer Diagnostics Ltd
11.2.6. BAG Diagnostics GmbH
11.2.7. Becton, Dickinson and Company,
11.2.8. Biofortuna Limited
11.2.9. BioMerieux SA,
11.2.10. Bio-rad Laboratories, Inc.
11.2.11. Biotype GmbH
11.2.12. Bruker,
11.2.13. CareDx Inc.
11.2.14. CLONIT srl
11.2.15. Diagnóstica Longwood SL
11.2.16. DiaSorin S.p.A.
11.2.17. ELITechGroup
11.2.18. EUROFINS VIRACOR
11.2.19. F. Hoffmann La-Roche AG.
11.2.20. Hologic, Inc.
11.2.21. Horiba Ltd
11.2.22. Illumina, Inc.
11.2.23. Immucor Transplant Diagnostics, Inc.
11.2.24. Laboratory Corporation of America Holdings.
11.2.25. Linkage Biosciences
11.2.26. Luminex Corporation
11.2.27. Merck KGaA
11.2.28. NanoString
11.2.29. Olerup SSP AB
11.2.30. Omixon Ltd.
11.2.31. PathoNostics
11.2.32. Preservation Solutions, Inc.
11.2.33. Qiagen N.V.
11.2.34. Randox Laboratories Ltd.
11.2.35. Stryker
11.2.36. Takara Bio Inc.
11.2.37. Thermo Fisher Scientific,
11.2.38. TransMedics
11.2.39. Transonic
11.2.40. Zimmer Biomet
11.2.41. Other Prominent Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Transplant Diagnostics Market Size is valued at USD 4.9 Bn in 2024 and is predicted to reach USD 10.4 Bn by the year 2034
Transplant Diagnostics Market expected to grow at a 7.9% CAGR during the forecast period for 2025-2034
BioMerieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Bio-Rad Laboratories, Bruker, and Merck KGaA
Product & Service, Application, Technology, Transplant Type, and End-User are the key segments of the Transplant Diagnostics Market.
North America region is leading the Transplant Diagnostics Market